Kintara Therapeutics Inc
NASDAQ:KTRA
Kintara Therapeutics Inc
NASDAQ:KTRA
Price:
6.3
USD
2 824.79%
Market Closed
Market Cap:
$266.4m
Balance Sheet
Balance Sheet Decomposition
Kintara Therapeutics Inc
Kintara Therapeutics Inc
Balance Sheet Decomposition is not available for
Kintara Therapeutics Inc
Kintara Therapeutics Inc
Balance Sheet
Kintara Therapeutics Inc
Kintara Therapeutics Inc
Currency: USD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
6
|
7
|
6
|
4
|
2
|
11
|
12
|
2
|
5
|
|
| Cash |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2
|
6
|
0
|
6
|
4
|
2
|
11
|
12
|
2
|
5
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
|
| Total Current Assets |
3
|
6
|
8
|
7
|
4
|
3
|
12
|
13
|
3
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
|
| Total Assets |
3
N/A
|
6
+147%
|
8
+24%
|
7
-11%
|
4
-43%
|
3
-27%
|
14
+361%
|
16
+18%
|
4
-75%
|
6
+56%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
2
-56%
|
1
-11%
|
2
+23%
|
2
+26%
|
3
+29%
|
3
+11%
|
4
+40%
|
3
-22%
|
2
-25%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
7
|
6
|
6
|
5
|
5
|
15
|
13
|
11
|
10
|
|
| Retained Earnings |
19
|
31
|
37
|
44
|
54
|
61
|
111
|
136
|
151
|
160
|
|
| Additional Paid In Capital |
17
|
29
|
37
|
43
|
51
|
57
|
107
|
136
|
141
|
153
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
5
N/A
|
7
+35%
|
5
-17%
|
2
-64%
|
0
-87%
|
11
+3 969%
|
12
+12%
|
1
-94%
|
4
+415%
|
|
| Total Liabilities & Equity |
3
N/A
|
6
+147%
|
8
+24%
|
7
-11%
|
4
-43%
|
3
-27%
|
14
+361%
|
16
+18%
|
4
-75%
|
6
+56%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
55
|
|
| Preferred Shares Outstanding |
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
